Related Experiment Video

Updated: Jul 10, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel

Fumio Sakashita1, Shinji Osada, Masao Takemura

  • 1Department of Surgical Oncology, Gifu Graduate School of Medicine, 1-1 Yanagido, Gifu City, Japan.

Cancer Chemotherapy and Pharmacology
|October 26, 2007
PubMed
Abstract

Insights

Paclitaxel (PTX) inhibits stomach cancer cell growth. p53 status and cyclin B1 expression may predict patient response to PTX therapy, guiding personalized treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Paclitaxel (PTX) is a key chemotherapy agent for various cancers.
  • The role of p53 status in PTX efficacy for stomach cancer remains incompletely understood.

Purpose of the Study:

  • To investigate the relationship between p53 status and paclitaxel-induced growth inhibition in human stomach cancer cells.
  • To explore the differential cellular responses to PTX based on p53 expression.

Main Methods:

  • Utilized two human stomach cancer cell lines (MKN45 and MKN28).
  • Assessed growth inhibition using MTT assays.
  • Analyzed cell cycle progression via flow cytometry.
  • Evaluated signaling molecule expression with Western blot analysis.

Main Results:

  • PTX demonstrated dose-dependent inhibition of proliferation in both cell lines, with greater cytotoxicity in MKN28 cells.
  • PTX induced sub-G1 arrest in MKN45 cells and G2/M arrest in MKN28 cells.
  • Cyclin B1 production increased in MKN28 cells, while cleaved caspase-3 increased in MKN45 cells following PTX treatment.
  • p53 inhibition (pifithrin-alpha) reduced cleaved caspase-3 in MKN45 cells.

Conclusions:

  • p53 status influences paclitaxel sensitivity in stomach cancer.
  • Cyclin B1 expression levels may serve as a predictive biomarker for PTX response.
  • These findings suggest potential biomarkers for tailoring PTX therapy in stomach cancer patients.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...